Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03698084

RESCEU: Defining the Burden of RSV Disease

Sponsor: University of Oxford

View on ClinicalTrials.gov

Summary

This observational study will determine the burden of RSV disease in at least 2000 healthy infants over 6 years until November 2026. The study will determine the incidence of acute respiratory tract infection (ARTI) associated with RSV, of medically attended ARTI and RSV related hospitalisation. Mortality (RSV associated and all-cause) through all RSV seasons and the health care costs, resource use and Health Related Quality of Life will also be determined. The study also aims to determine important risk factors for RSV infection (by severity and healthcare utilisation.

Official title: REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Study: Defining the Burden of Respiratory Syncytial Virus (RSV) Disease.

Key Details

Gender

All

Age Range

Any - 12 Months

Study Type

OBSERVATIONAL

Enrollment

2000

Start Date

2017-09-05

Completion Date

2026-11-30

Last Updated

2022-10-27

Healthy Volunteers

No

Interventions

PROCEDURE

venepuncture

sample collection for analysis

PROCEDURE

nasopharyngeal swab

sample collection for analysis

Locations (1)

University of Oxford

Oxford, Oxfordshire, United Kingdom